𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tentative dose-monitoring of doxorubicin in lymphoma patients

✍ Scribed by J. Robert; P. Vrignaud; H. Eghbali; T. Nguyen-Ngoc; B. Hoerni

Book ID
112944231
Publisher
Springer US
Year
1985
Tongue
English
Weight
346 KB
Volume
2
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Multicenter study of pegylated liposomal
Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma
✍ Uwe Wollina; Reinhard Dummer; Norbert H. Brockmeyer; Helga Konrad; J.-O. Busch; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 96 KB

## Abstract ## BACKGROUND In single center studies and case reports, it was shown that pegylated liposomal doxorubicin (PEG‐DOXO) was effective as second‐line therapy for patients with cutaneous T‐cell lymphoma (CTCL). The objective of this study was to evaluate the efficacy and toxicity of single